SEC Form 5 · accession 0000899243-19-003439
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H. Gardner
Officer — President · Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 13, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 12, 2018 | G | 150,000 | $0.00 | D | 443,019 | D | |
| Common StockF1 | Dec 12, 2018 | G | 150,000 | $0.00 | A | 150,000 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 12, 2018, the reporting person gifted these shares to a family trust for the benefit of the reporting person's children. The reporting person's sibling is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.